Clozapine, eating disorders and substance abuse. Obstacles to innovation in a peripheral hospital.
Launer
M
M
D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002908:Chronic Disease; D003024:Clozapine / Q000009:adverse effects / Q000627:therapeutic use*; D003363:Cost Control / Q000639:trends; D003695:Delivery of Health Care / Q000191:economics; D004059:Diffusion of Innovation; D001068:Feeding and Eating Disorders / Q000534:rehabilitation*; D006556:Heroin Dependence / Q000534:rehabilitation*; D006801:Humans; D011785:Quality Assurance, Health Care / Q000191:economics*; D012559:Schizophrenia / Q000534:rehabilitation*; D006113:United Kingdom
D014150:Antipsychotic Agents; D003024:Clozapine